Senseonics Revenue and Competitors
Estimated Revenue & Valuation
- Senseonics's estimated annual revenue is currently $36.1M per year.
- Senseonics received $149.5M in venture funding in July 2018.
- Senseonics's estimated revenue per employee is $258,171
- Senseonics's total funding is $455.5M.
Employee Data
- Senseonics has 140 Employees.
- Senseonics grew their employee count by 17% last year.
Senseonics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Manager, Quality Sciences | Reveal Email/Phone |
3 | Staff Accountant | Reveal Email/Phone |
Senseonics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2320M | 7682 | 9% | $413.7M | $43.4B |
What Is Senseonics?
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
keywords:Biotechnology,Hardware,Healthcare,Medical Devices,Pharmaceuticals
$455.5M
Total Funding
140
Number of Employees
$36.1M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Senseonics News
Zacks: Analysts Anticipate Senseonics Holdings, Inc. (NYSE:SENS) Will Announce Quarterly Sales of $2.14 Million. Posted by admin on Apr 23rd,...
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed...
Senseonics Holdings has launched the Eversense E3 continuous glucose monitoring and has announced the first commercial implant of the device.
Other Companies in Germantown
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $43.7M | 147 | -3% | N/A |
#2 | N/A | 153 | 32% | N/A |
#3 | $24.6M | 154 | N/A | N/A |
#4 | $46M | 155 | 2% | N/A |
#5 | $46.3M | 156 | -2% | N/A |
Senseonics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2002-04-19 | $30.0M | C | Article | |
| 2005-11-04 | $Undisclosed | Undisclosed | Multiple | Article |
| 2011-11-02 | $54.0M | D | Delphi Ventures | Article |
| 2014-06-09 | $20.0M | Undisclosed | Multiple | Article |
| 2014-08-20 | $10.0M | Undisclosed | Oxford Finance LLC | Article |
| 2015-08-14 | $10.0M | Undisclosed | Article | |
| 2016-07-08 | $30.0M | Undisclosed | Oxford Finance LLC | Article |
| 2017-05-29 | $41.0M | Undisclosed | Leerink Partners LLC | Article |
| 2017-08-21 | $28.8M | Undisclosed | National Securities Corporation | Article |
| 2018-01-29 | $55.3M | Undisclosed | BTIG | Article |
| 2018-07-03 | $149.5M | Undisclosed | Article |